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Background: All patients with congenital heart disease (CHD) are chronically ill from their cardiac 
disease. Despite the increasing evidence that aortic alterations are becoming relevant, the importance of 
aortopathy in CHD has long been underestimated. This study was conducted to determine the health status 
of patients and/or the provision of health services of adults with CHD (ACHD) with manifest aortopathy or 
at risk thereof. 
Methods: In a questionnaire-based cross-sectional survey, the “real life”-care of ACHD was analysed, 
comparing patients with risk of developing aortopathy and/or manifest aortopathy. 
Results: Of the 563 enrolled ACHD (49.6% female, mean age 35.8±12.1, 18–86 years) 56.8% (n=320) had 
a risk of developing aortopathy and/or manifest aortopathy. Of the 320 patients at risk, 187 (33.2% of the 
total number) had a proven aortopathy. Within this subgroup, the basic medical care for CHD-independent 
medical problems was given by primary medical care providers [family doctors/general practitioners (GP) in 
89.4% (n=286), internists in 13.4% (n=43), physicians of another specialty in 2.5% (n=8)]. Almost all primary 
medical care providers knew about the CHD of their patients. Even for CHD-specific health problems, 
the basic medical care of risk patients was provided by a family doctor or GP in 56.6% (n=181) and by an 
internist in 18.4% (n=59). 30.0% (n=96) primarily consulted another specialist, including cardiologists. Only 
32.8% of ACHD at risk had ever been referred to a CHD specialist by a GP for cardiac problems related 
to their CHD. In contrast, the need for advice was high for ACHD with aortopathy and related mainly to 
physical activity, employment and education, pregnancy, rehabilitation or health and life insurance. Only 
35.5% of patients at risk indicated that their information on specific care structures for ACHD was sufficient, 
and a further 38.1% of patients were aware of patient organizations. 
Conclusions: Even today, aortic involvement in ACHD is an often-overlooked condition, although 
considerable negative effects on morbidity and mortality exist. As aortopathy gains in importance with 
increasing age and complexity of CHD, almost all affected ACHD need lifelong medical advice and access 
to modern, scientifically based care concepts. According to the study-results, primary care providers and 
also patients are mostly insufficiently informed about the specialized ACHD facilities. The future goal 
is therefore to create a better awareness of CHD problems among both primary care physicians and the 
patients concerned.
528
Original Article on Current Management Aspects in Adult Congenital Heart Disease (ACHD): Part III
519Cardiovascular Diagnosis and Therapy, Vol 11, No 2 April 2021
© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2021;11(2):518-528 | http://dx.doi.org/10.21037/cdt-20-359
Introduction
Congenital heart anomalies are the most common isolated 
congenital organ malformations with an estimated incidence 
of 8/1,000 live births for congenital heart disease (CHD) 
and every year more than 1.35 million children are born 
worldwide with CHD (1-3).
Today, almost all types of CHD have become amenable 
to surgical or interventional treatment and more than 90% 
of all affected patients reach adulthood (4-6). Accordingly, 
around 50 million adults with CHD (ACHD) live at present 
worldwide (1).
However, despite of all advances, ACHD are and remain 
chronically ill from their cardiac disease, and many affected 
patients still have residua and sequelae of their CHD 
which contribute to an increased morbidity and mortality 
compared to the normal population (7-13).
For most CHD, heart defect specific cardiac residua or 
sequelae have to be expected, including heart failure, cardiac 
arrhythmias, pulmonary vascular disease with pulmonary/
pulmonary arterial hypertension and a risk of infective 
endocarditis (4,7,14).
In the meantime, there is increasing evidence that also 
aortic alterations become relevant in ACHD. However, 
the importance of aortic diseases in CHD has long been 
underestimated and remains an often-overlooked condition, 
although it gains importance with increasing age and 
complexity of CHD.
Because of the listed potential residua and sequels, almost 
all patients with native, interventional or surgically treated 
CHD require lifelong follow-up care. This is mostly offered 
by general practitioners, family physicians and general 
internists (i.e., “primary care”), sometimes by cardiologists 
and only in a minority of cases by specifically trained and 
experienced congenital cardiologists or by cardiac centers 
for ACHD.
The aim of the current survey was to acquire real 
world data on the health status of patients and/or the 
provision of health services in ACHD associated with aortic 
abnormalities by general practitioners, family doctors 
and general practitioners (i.e., “primary care providers”). 
We present the following article/case in accordance with 




In this cross-sectional clinical study, 563 patients from a 
tertiary care center for ACHD (Department of Congenital 
Heart Disease and Pediatric Cardiology, German Heart 
Center Munich, Technical University Munich, Munich, 
Germany) were included. Patients were consecutively 
included in the order that they presented at the institution 
and were not selected in prior. The study was part of a 
nationwide study to assess the care situation of the ACHD 
throughout Germany (“VEmaH study”). The survey 
has been approved by the institutional review boards of 
the Technical University Munich (157/16 S) and written 
informed consent was obtained from all participating 
patients before the start of documentation. Participation 
or non-participation in this study had no influence on 
the medical care of the patients. Guidelines on good 
pharmacoepidemiological practice (GPP) and data 
protection guidelines were followed. 
Patient inclusion
Inclusion criteria for the present study were a confirmed 
diagnosis of CHD, and adult age (>18 years). Exclusion 
criteria were lack of cognitive competence to consent to 
research, and refusal to consent. 
Medical records were reviewed for patient demographics, 
cardiac and non-cardiac diagnosis. Accordingly, patients 
were assigned to one out of six classes of diagnosis.
Questionnaire
As this is the first study to explore the “real world data” 
on the health status of patients and/or the provision of 
health services in ACHD, it was not possible to use a 
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standardized and validated questionnaire. For this purpose, 
a questionnaire was specifically devised in cooperation with 
the Chair of Behavioral Epidemiology at the Technical 
University of Dresden and the German Heart Center 
Munich as tertiary care center for ACHD.
This questionnaire contains questions related to the 
sociodemographic situation, the CHD, co-morbidities, 
care providers for medical problems in general and CHD-
related problems, individual demands of the patients 
for counselling, knowledge of specific care structures 
and problems with the care situation from the patient’s 
perspective. The questionnaire was completed either 
directly during the stay at the hospital or online on the 
homepage of the study (http://www.vemah.info). 
Patient classification
At first stage, the patients were classified according to the 
underlying CHD and consecutively assigned to 1 of 6 major 
diagnosis groups depending on the type of the underlying 
CHD: complex CHD (I), disorders of the left heart/
anomalies of the aortic valve or aorta (II), disorders of the 
right heart/ anomalies of pulmonary valve or pulmonary 
artery (III), primary left-to-right shunt lesions—either at 
pre-tricuspid or post-tricuspid level (IV), genetic syndromes 
(V), or other congenital non-classifiable congenital heart 
anomalies (VI).
According to the underlying pathological anatomy, 
pathophysiology, and epidemiological data from the recent 
literature, ACHD were divided into the two groups “at risk 
for developing aortopathy and/or manifest aortopathy” or 
“without risk of intrinsic aortopathy”. 
The “aortopathy” in the current cohort was defined 
either depending on the underlying disease with “intrinsic” 
pathologic aortic alterations or depending on the reported 
absolute diameter of the aortic root or the ascending aorta. 
“Intrinsic” pathologic aortic alterations with abnormality of 
vessel architecture were presumed according to data from 
the literature for syndromic and non-syndromic congenital 
or hereditary congenital anomalies (15).
In the present survey, an absolute diameter of the aortic 
root or the ascending aorta of >38 mm in a normal sized 
adult was considered pathologic, without correcting the 
normal range for age, weight, sex or body surface area. This 
seems suitable for this overview survey, since the definition of 
a “normal aorta size” is still under discussion and robust data 
on aortic size in the “normal” population are missing (16), 
particularly in patients with CHD.
Statistical analysis
The data analysis was performed using SPSS 23.0 (IBM 
Inc., Armonk, NY, USA). All statistical evaluations of the 
data were pseudonymized and not person-related.
Descriptive statistical methods were used for data 
analysis and initial characterization of the study population. 
Differences between the groups were checked and evaluated 
using Chi-squared tests. T-tests were used for comparisons 
between mean values. Continuous data was expressed as 
mean ± standard deviation, categorical or interval scaled 
variables as absolute numbers or percentages. All occurring 
P values and tests for significance were performed two-
sided. A P value <0.05 was considered significant. 
Since multiple answers were permitted for some 
questions, the number of received answers may differ from 
the total number of study participants included.
Results
Study sample and patient characteristics
A total of 563 patients with a proven hereditary or 
congenital heart defect were suitable for the present analysis 
and were enrolled. The underlying anomaly could be 
assigned to one of six different main groups (I–VI) (Table 1). 
Out of the 563 consecutively enrolled patients with CHD 
320 (56.8%) had a risk of developing aortopathy. Of the 
320 patients at risk, 187 (33.2% of the total number) had 
a proven aortopathy according to medical notes or by 
definition (Table 1).
Epidemiological data 
The mean age of all patients at the time of the survey was 
35.8±12.1 years (range, 18 to 86 years). Most patients 
were in their third, fourth and fifth decade of life (n=455; 
80.8%). Thirty-five patients (6.2%) were younger than 
20 years, 73 older than 50 years (13.0%). In terms of gender 
distribution, 279 patients (n=49.6%) were female. 
Comparing the age distribution within the two groups 
“at risk/manifest aortopathy” and “without intrinsic 
aortopathy”, the patients at risk were significantly younger 
[34.3±10.8 years (range, 18 to 86 years) versus 37.7±13.3 years 
(range, 18 to 77 years)] and female patients were fewer 
[40.3% (n=129 of 320) versus 61.7% (n=150 of 243)].
The body mass index of all included patients was 
24.7±4.4 kg/m2 (range, 13.8–49.3 kg/m2), with no significant 
difference between both groups at risk/manifest aortopathy 
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Table 1 Main diagnosis of the included 563 patients with congenital heart disease with/without aortopathy and also the number of patients with 
proven aortopathy according to medical notes or by definition
Congenital heart disease
Total number (%) of 
patients
At risk for developing 
aortopathy
Proven aortopathy 
(according to medical 
notes or by definition**)
I. Complex anomalies 148 out of 563 (26.3%) 74 out of 148 (50.0%) –
Discordant atrio-ventricular or ventricular arterial 
connections, including:
86 64 –
Transposition of the great arteries 61 61 6
TGA-atrial switch 43 43 2
TGA-arterial switch 15 15 3
TGA-Rastelli 3 3 1
Congenitally corrected TGA 22 – –
Double outlet right ventricle-TGA 3 3 1
Univentricular hearts, including: 23 – –
Double inlet ventricle 9 – –
Tricuspid atresia 14 – –
Pulmonary atresia with intact septum 6 – –
Truncus arteriosus communis 4 4 4
Other complex CHD including: 29 6 2
Ebstein’s anomaly 23 – –
Others 6 6 –
II. Anomalies of the left heart, the aortic valve or aorta 124 out of 563 (22.0%) 124 out of 124 (100.0%) –
Bicuspid aortic valve/aortic valve anomalies 52 52 38**
Aortic stenosis (sub- and supra-valvular) 9 9 2**
Interrupted aortic arch 2 2 2**
Aortic coarctation 61 61 61**
III. Disorders of the right heart/anomalies of pulmonary 
valve or pulmonary artery
98 out of 563 (17.4%) 75 out of 98 (76.5%) –
Tetralogy of Fallot 54 54 14
Double outlet right ventricle of Fallot type 7 7 3
Pulmonary atresia with ventricular septal defect 14 14 10
Pulmonary valve anomaly and pulmonary artery anomaly 23 – –
IV. Primary left-to-right shunt lesions at pre-tricuspid or 
post-tricuspid level
130 out of 563 (23.1%) 11 out of 130 (8.5%) –
Atrial septal defect 38 1* 1*
Persistent foramen ovale 14 1* 1*
Partial atrio-ventricular septal defect 8 2* 2*
Table 1 (continued)
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(24.6±4.1 kg/m2; range, 13.8–41.9 kg/m2) compared to the group 
w/o intrinsic risk (24.9±4.8 kg/m2; range, 16.4–49.3 kg/m2) 
(P=0.480). 
Basic medical care for general, CHD-independent medical 
problems 
As shown by the study data, basic medical care was in the 
entire group of ACHD in 88.9% (n=501 answers) provided by 
family doctors, general practitioners, internists and sometimes 
physicians of another specialty as first consultation partners.
When asked about their primary medical care provider 
for general, CHD-independent, medical issues, in the group 
“at risk/manifest aortopathy” 337 answers were given. 
Eighty-nine point four percent (n=286) of the responders 
consulted a general practitioner/family doctor in such cases, 
while 13.4% (n=43) contacted an internist. Only 2.5% (n=8) 
of the patients indicated that their first correspondent had a 
different medical specialization (multiple answers possible). 
In the group “without intrinsic aortopathy” 264 answers 
were received. In 88.5% (n=215) of cases, a general 
practitioner/family doctor was primarily consulted, in 
13.2% (n=32) an internist, in 7.0% (n=17) a physician with 
another medical specialization (multiple answers possible).
In the entire group, according to the study participants, 
94.3% of the above-mentioned primary medical care 
providers were aware that the patient has a CHD. The 
remaining 5.7% of the providers were unaware of their 
patients’ CHD or the study participants stated that they 
did not know whether their primary care provider had 
knowledge of their existing CHD. There was no significant 
difference between the groups “at risk/manifest aortopathy” 
or “without intrinsic aortopathy”.
Basic medical care for CHD-dependent medical problems
In response to the question on the primary contact 
physician for CHD-specific health problems, 585 answers 
(multiple answers possible) were received. Even in the 
case of heart problems, in the group “at risk/manifest 
aortopathy”, 56.6% (n=181) of the responders were cared 
for by a general practitioner/family doctor, 18.4% (n=59) 
by an internist, and 30.0% (n=96) patients primarily by a 
doctor with a different specialization, including cardiology. 
Similarly, in the group “without intrinsic aortopathy” 
51.0% (n=124) of the patients primarily consulted a general 
Table 1 (continued)
Congenital heart disease
Total number (%) of 
patients
At risk for developing 
aortopathy
Proven aortopathy 
(according to medical 
notes or by definition**)
Partial anomalous pulmonary venous return 2 – –
Total anomalous pulmonary venous return 4 – –
Ventricular septal defects 45 3* 3*
Complete atrio-ventricular septal defect 15 – –
Patent ductus arteriosus Botalli 4 4 1**
V. Genetic syndromes 35 out of 563 (6.2%) 35 out of 35 (100.0%) –
Marfan- or Loeys-Dietz syndrome 29 29 29**
Aortic aneurysm of unknown origin 6 6 6**
VI. Non-classifiable CHD (“other”) 28 out of 563 (5.0%) 1 out of 28 (3.6%) –
Congenital cardiomyopathy 5 – –
Congenital valve anomaly 11 1 1
Congenital other 12 – –
Total 563 320 187
*, without expected risk of aortopathy, but with manifest aortopathy according to the medical records; **, aortopathy by definition. CHD, 
congenital heart disease; TGA, transposition great arteries.
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practitioner/family doctor, 18.5% (n=45) an internist, 
and 32.9% (n=80) primarily a doctor with a different 
specialization, including cardiology.
Transfer to an institution specialized in CHD because of a 
medical problem 
Only 32.8% (n=105) of CHD-patients “at risk/manifest 
aortopathy” reported that a general practitioner/family 
doctor had referred them to a CHD-specialist in the past 
because of cardiac problems related to their CHD. Forty-
nine-point-four percent (n=158) have never been referred 
to a CHD-specialist. 
Also, in the group “without intrinsic aortopathy”, only 
33.7% (n=82) of patients had been referred to a CHD-specialist 
because of cardiac problems related to their CHD. Even 49.4% 
(n=120) have never been referred to a CHD-specialist.
Specific counselling needs for advice for patients with CHD 
with and without aortopathy
The question in which areas a specific advice is required 
was answered by the study participants with multiple 
responses. In all groups, the greatest need for counselling 
was reported with respect to the ability to perform during 
physical or sporting activity, to employment and education, 
to pregnancy and inheritance, to rehabilitation measures, and 
also to driving license, the ability to travel and to air travel. 
Moreover, there was also a specific need for information 
about health insurance, life insurance and retirement (Table 2).
Patients knowledge about targeted care for ACHD in 
Germany
All patients were asked about the awareness of certificated 
facilities for the care of ACHD. Certificated and accredited 
pediatric cardiologists, adult cardiologists, specialized 
hospitals and heart centers for ACHD were widely 
unknown to the majority of all affected patients. There was 
no significant difference between both groups of “ACHD at 
risk” and “without risk of intrinsic aortopathy”.
The question of whether the information on specific care 
structures for ACHD is sufficient was answered by 293 of 
the 320 participating ACHD “at risk” [91.6%; missing data 
Table 2 Counselling needs and requests of all patients with congenital heart disease, patients “at risk for aortopathy” and in patients “without risk 
of intrinsic aortopathy”
Counselling needs and requests Overall, % [n] At risk for aortopathy, % [n] “Without intrinsic aortopathy”, % [n] P value
Exercise capacity 44.9 [253] 45.9 [147] 43.6 [106] 0.584
Everyday burden 38.0 [214] 39.1 [125] 36.6 [89] 0.555
Age insurance 32.9 [185] 34.4 [110] 30.9 [75] 0.039*
Life insurance 29.3 [165] 30.6 [98] 27.6 [67] 0.561
Health insurance 28.6 [161] 26.9 [86] 30.9 [75] 0.776
Pension, retirement 29.7 [167] 30.0 [96] 29.2 [71] 0.841
Career opportunities 28.2 [159] 28.1 [90] 28.4 [69] 0.944
Severe disability 28.8 [162] 30.6 [98] 26.3 [64] 0.266
Rehabilitation measures 24.3 [137] 25.3 [81] 23.0 [56] 0.535
Pregnancy 26.6 [150] 22.8 [73] 31.7 [77] 0.018*
Genetic counselling 20.6 [116] 20.6 [66] 20.6 [50] 0.989
Airworthiness 16.9 [95] 14.4 [46] 20.2 [49] 0.069
Education forms 6.4 [36] 5.6 [18] 7.4 [18] 0.392
Driving license 4.4 [25] 3.8 [12] 5.3 [13] 0.361
Other needs 2.7 [15] 0.6 [2] 5.3 [13] 0.001*
*, significant. n, absolute number.
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in 27 (8.4%)]. Only 35.5% (n=104 of 293) participating 
patients answered positively, another 29.4% (n=86 of 293) 
were undetermined. In patients “without risk of intrinsic 
aortopathy” 224 of the 243 participants answered [92.2%; 
missing data in 19 (7.8%)]. Only 33.0% (n=74 of 224) 
participating patients answered positively, another 29.5% 
(n=66 of 224) were undetermined. There was no significant 
difference between both groups (P=0.812).
Patients knowledge about patient organizations for ACHD 
in Germany
All patients were asked whether they knew patient 
organizations for ACHD. This question was answered 
by all 563 study participants. Similar to targeted medical 
institutions, patient organizations for ACHD were also 
widely unknown to the majority of affected patients.
In the group of ACHD “at risk” the question was 
answered positively by only 38% (n=122) of participating 
patients, another 10% (n=32) were undetermined. In 
patients “without risk of intrinsic aortopathy” also only 35% 
(n=86) participants answered positively, another 12% (n=30) 
were unsure (Figure 1). There was no significant difference 
between both groups (P=0.615).
Patient satisfaction in the context of medical care for their 
CHD
The question concerning satisfaction in the context 
of medical care for their CHD was answered by 545 
study participants (missing data n=18). On a scale of 1–6 
(1= very good; 6= unsatisfactory), 311 patients with 
aortopathy (missing data n=9) rated their medical care on 
average 1.87 (very good–good). The 234 patients (missing 
data n=9) without risk gave an average 1.81 (very good–
good). There was no significant difference between both 
groups (P=0.414) (Figure 1).
Discussion
Clinical relevance of the study
This is the first study to explore the medical care provided 
by primary care physicians (family doctors, general 
practitioners, or internists) within a large sample of adults 
with almost all types and severities of CHD and associated 
risk of having or developing an aortopathy.
Our data indicate that, even in this vulnerable patient group, 
family doctors and/or general practitioners are in fact the 
first medical care providers when a general medical problem 
arises. These first physicians consulted include family doctors 
and/or general practitioners in 89.4%, internists in 13.4%, 
and physicians of another specialty in 2.5% (multiple answers 
permitted). It is remarkable, that almost all of these physicians 
are aware that their patient has a CHD. 
It is however of concern that family doctors and/
or general practitioners and internists are also the first 
consultants to be contacted for CHD-specific health 
problems. Under these conditions, family doctors or 
general practitioners are approached in 56.6%, internists 
in 18.4% and a doctor of another specialty, including 
cardiology, in at least 30% of cases. This is especially 
problematic, as many primary care physicians are usually 
not specifically trained, not experienced in CHD care 
and unaware of the long-term problems of ACHD. This 
may even have more severe consequences in view of the 
ever-growing number of CHD-patients, all of which are 
chronically ill due to residua and sequelae of the underlying 
cardiovascular abnormality. Therefore, the spectrum of 
long-term problems is so widespread that it can only be 
mastered by CHD-experienced specialists. As described 
initially, it includes in particular the residual and subsequent 
conditions specific to the heart defects, including heart 
failure, cardiac arrhythmias, pulmonary vascular disease/
pulmonary hypertension and endocarditis. 
In addition, depending on the underlying congenital 
heart anomaly, aortic alterations become more and 
more relevant with increasing age. Nevertheless, aortic 
involvement in CHD remains an often-overlooked 
condition, although considerable negative effects on 










At risk for aortopathy
No intrinsic risk for aortopathy
Very good (1)    Good (2)   Satisfactory (3)  Sufficient (4)    Poor (5)      Deficient (6)
Figure 1 Patients’ satisfaction in the context of medical care for 
their congenital heart defects in percent (%).
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Aortopathy in genetically determined, syndromic disorders 
with aortic involvement or in patients with CHD
Aortopathy, defined as progressive dilatation of the proximal 
aortic root, ascending or descending aorta, is frequently found 
in genetically determined, syndromic disorders with aortic 
involvement (e.g., Marfan-syndrome), as well as in the natural 
or in the postoperative / postinterventional course in CHD (18). 
“Aortopathy” is generally characterized by degeneration of 
the aortic wall layer with aortic medial degeneration, which 
is associated with aortic dilation or aneurysm formation as 
well as aortic-ventricular interaction (15). 
Aortic medial degeneration is well recognized and reaches 
its most severe form in genetic determined disorders like 
Marfan syndrome with annuloaortic ectasia. It is also seen 
in Loeys-Dietz syndrome, other connective tissue disorders 
with vascular involvement such as vascular Ehlers-Danlos 
syndrome, as well as Turner- or Noonan-syndrome (19). 
The changes in aort ic  medial  degenerat ion are 
inappropriately called “cystic medial necrosis”, although 
no “cysts” can be found histopathologically. This process 
is rather characterized by elastic fiber degeneration and 
fragmentation, non-inflammatory loss of smooth muscle 
cells, and with accumulation of basophilic ground substances 
within cell-depleted areas in the media (20).
In other CHD, the above mentioned aortic medial 
degeneration is qualitatively similar, but seldom quantitatively 
so pronounced as in Marfan syndrome. Such alterations 
occur not only in complex but also in simple CHD. In 
conotruncal anomalies, like Tetralogy of Fallot, pulmonary 
atresia, truncus arteriosus, the process of dilatation already 
starts in the prenatal period and the dilatation is flow-related. 
Besides, aortopathy reflects a common developmental fault 
that weakens the aortic wall and causes aortic dilatation, 
decreases aortic elasticity and increases aortic stiffness 
(14,18,21,22). At least in some congenital heart anomalies, 
the hypothesis of aortic dilatation has shifted from so called 
“poststenotic dilatation” to “primary intrinsic” aortopathy.
According to the literature, aortic dilatation and aortic 
aneurysms occur or develop in many different CHD. 
Aortopathy is associated particularly with a bicuspid aortic 
valve, aortic coarctation, conotruncal anomalies such as 
tetralogy of Fallot, pulmonary atresia with ventricular septal 
defect, complete transposition of the great arteries, truncus 
arteriosus communis, double outlet right/left ventricle, or 
aorto-pulmonary window or aortic arch anomalies. Also, 
certain patients with univentricular hearts or hypoplastic 
left heart syndrome after modified Fontan-operation are 
susceptible (23-26). In addition, aortopathies are frequently 
seen after any operative treatment involving the aorta, e.g., 
after arterial switch operation for transposition of the great 
arteries, or after Ross-operation.
The assumption that the aorta is affected in many CHDs 
is supported by the large numbers of unselected patients 
in the present study, where out of the 563 consecutively 
enrolled ACHD, 320 (56.8%) had a risk of developing 
aortopathy and/or manifest aortopathy. A proven aortopathy 
had 57.9% (n=185) of the patients at risk (n=320) and 32.5% 
of all included patients (n=563). The patients at risk for 
developing aortopathy and/or manifest aortopathy were 
predominantly from the group of complex CHD [74 out of 
148 (50.0%)], anomalies of the left heart, of the aortic valve 
or the aorta [124 out of 124 (100.0%)], disorders of the right 
heart/ anomalies of pulmonary valve or pulmonary artery 
[75 out of 98 (76.5%)] or, genetic syndromes with aortic 
involvement [35 out of 35 (100.0%)].
Clinical relevance of aortopathy in patients with CHD
Clinically relevant is the fact, that such an aortopathy may 
progress and put the affected patients at risk for aortic 
aneurysm formation and aortic dissection or rupture. 
In order to prevent such devastating aortic complications, 
particularly aortic dissection or rupture, it would be essential 
to identify high-risk patients at an early stage and, if 
necessary, to treat them prophylactically or to provide them 
with appropriate surgical treatment in a timely manner. 
Thereby, it is important to know that the decision-making 
process is strongly dependent on the underlying diagnosis of 
the CHD or the underlying disease (e.g., Marfan syndrome). 
For the medical prophylaxis of the progression of aortic 
widening, for example, data are available for patients with 
Marfan syndrome at best, but not for aortopathies in other 
forms of CHD. 
It should also be noted that the indication for prophylactic 
surgery in adults with acquired, degenerative forms of aortic 
aneurysm only apply to a limited extent to aortopathies in CHD.
Moreover, aortic dilatation and increased aortic stiffness 
can induce progredient aortic valve regurgitation, left 
ventricular hypertrophy, reduced coronary artery flow and 
left ventricular failure (21,22,27).
The care of patients with aortopathy in patients with CHD
All these facts indicate that ACHD require targeted care and 
follow-up by experienced specialists. 
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Starting around the year 2006, in Germany for this 
reason, pediatric cardiologists and cardiologists who had 
sufficient experience in the care of ACHD have been 
certificated. In addition, medical practices, specialist clinics 
and centers for the care of ACHD were also accredited. 
In the meantime, similar to Canada, as of 03/2020 
Germany has a nationwide network of more than 348 
certified pediatric cardiologists and cardiologists in private 
practice, 11 certified regional centers and 19 certified 
supra-regional, tertiary care centers for ACHD. However, 
as reflected by preliminary data of the VEmaH-study, 
the problem is that most patients with CHD in Germany 
do not reach these centers at all (28-30). This fact is 
consistent with the patients’ statements, that about 50% of 
the surveyed patients indicated that they have never been 
referred to a CHD specialist for cardiac problems related 
to their CHD. It could also be explained, at least in part, by 
the globally known “loss to follow” phenomenon.
In addition, also the knowledge of patients about the 
nationwide availability of specialists and centers for the 
treatment and follow-up of their CHD is completely inadequate. 
Only 36% of all patients who responded indicated that their 
information on specific care structures for CHD was sufficient. 
Furthermore, only 37% of all responders were aware of 
the existence of patient organizations for CHD.
Finally, some criticism must be directed towards the study 
center. Although the German Heart Center Munich is the 
largest center in Germany for the care of ACHD, many of 
the patients treated here and many referring physicians are 
obviously unaware of this fact. Most patients of the Heart 
Center are in a continuous follow-up for years or decades. 
For them this is routine. Since they do not perceive deficits in 
cardiological care, they are not thinking about care structures. 
This equally applies to the referring physicians. 
However, the patient satisfaction with medical follow-
up care mainly concerns cardiological aspects. Present study 
results suggest, that there is an unmet need for further 
information and consulting. This concerns in particular 
aspects such as exercise, nutrition, life style, rehabilitation, 
prevention and socio-medical aspects such as old-age 
security. This lack of awareness is most likely due to 
inadequate educational and information work by the Heart 
Center and needs urgent improvement.
Limitations
The present study engaged a remarkably large sample size 
of recruited patients with almost all types and severities of 
CHD. However, current results should be interpreted in 
the light of certain limitations. 
First, only patients who voluntarily agreed to participate 
were enrolled. The extent to which the patients’ motivation 
to voluntarily participate remains unknown and may 
have biased the observations, as patients who voluntarily 
participate in research surveys differ from those who choose 
not to participate. 
Further, it is possible that the number of patients with 
manifest aortopathy is even higher than indicated. This 
may be likely due to the fact that only those patients 
were classified as “manifest”, in whom an aortopathy was 
intrinsic or pathological aortic diameters were described 
in the medical records. The difficulties in interpreting 
the measured values can be explained by the fact that the 
aorta can often not be adequately visualized by routine 
transthoracic echo examinations. In adults, only the first 
few centimeters of the ascending aorta can often be seen. 
However, more advanced examinations, such as cardio-
MRI, CT or aortography, which allow the entire aorta to be 
examined, were not routinely performed.
In addition to the absolute size of the aorta, the progression 
of the aortic diameter over the time would be important for 
the risk assessment of the affected patients. We have not 
considered this aspect in our study, as it was a cross-sectional 
study from the outset and not a longitudinal study. 
This study was performed at a tertiary care center for 
ACHD. Thus, the sample of patients does not represent the 
typical population of CHD seen by a general practitioner or by 
a cardiologist. The prevalence of more complex anomalies in 
these institutions is likely to be higher than either in community-
based hospitals or even in departments for cardiology. 
Lastly, the presented data derive solely from patients 
living in Germany. Generalization of the conclusions 
and transmission to patients living in other countries or 
different culture groups is debatable. 
Conclusions
Although today most patients with CHD survive into 
adulthood, many of them have relevant residua and sequels, 
including aortopathy. Even today it is not rarely overlooked, 
that such aortopathy can cause significant morbidity and 
mortality, particularly with increasing age. This does not 
only apply to the rapidly increasing number of adults with 
complex CHD, but also to simple treated or untreated 
CHD, which were considered harmless until recently. 
Therefore, the awareness of patients as well as treating 
527Cardiovascular Diagnosis and Therapy, Vol 11, No 2 April 2021
© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2021;11(2):518-528 | http://dx.doi.org/10.21037/cdt-20-359
physicians about aortopathies and associated potential risks 
must be increased to close actual gaps in patient care.
An experienced routine follow-up care by specialized 
and/or certified physicians or centers is imperative for 
all patients with CHD, and in particular for those with 
intrinsic aortopathy or at risk for aortopathy. 
Finally, as the presented data derive from people 
living in Germany, further studies are needed to assess 
the situation of CHD-patient care in other countries. In 
a next step further data from other countries might be 
collected for comparison purposes in order to establish 
practical international guidelines for the management of the 
increasing number of ACHD.
Acknowledgments
The authors thank the German Heart Foundation 
(“Deutsche Herzstiftung e.V.”), the patient organization 
“Herzkind e. V.”, and also the German health care 
insurance AOK-Bayern for the promotion of ACHD 
research. This article contains parts of the doctoral thesis of 
A. Kaemmerer, University of Szeged, Hungary. 
Funding: This work was supported by the German Heart 
Foundation (“Deutsche Herzstiftung e.V.”) (grant number 
F-30-15), the patient organization “Herzkind e.V.”, Actelion 
Pharmaceuticals Germany GmbH (grant number MED-2015-
495) and the German healthcare insurance AOK-Bayern.
Footnote
Guideline Checklist: The authors have completed the 
SURGE guideline checklist. Available at http://dx.doi.
org/10.21037/cdt-20-359
Data Sharing Statement :  Available at http://dx.doi.
org/10.21037/cdt-20-359
Provenance and Peer Review: This article was commissioned 
by the Guest Editors (Yskert von Kodolitsch, Harald 
Kaemmerer, Koichiro Niwa) for the series “Current 
Management Aspects in Adult Congenital Heart Disease 
(ACHD): Part III” published in Cardiovascular Diagnosis and 
Therapy. The article has undergone external peer review.
Conflicts of Interest: All authors have completed the 
ICMJE uniform disclosure form (available at http://dx.doi.
org/10.21037/cdt-20-359). The series “Current Management 
Aspects in Adult Congenital Heart Disease (ACHD): Part 
III” was commissioned by the editorial office without any 
funding or sponsorship. CA, PE, SF, ASK, NN, LP, KN, 
RN, and LS report grants from Deutsche Herzstiftung 
(Patient organization), grants from Herzkind e.V. (Patient 
organization), grants from Actelion Deutschland, during 
the conduct of the study. The other authors have no other 
conflicts of interest to declare.
Ethical Statement: The authors are accountable for all 
aspects of the work in ensuring that questions related 
to the accuracy or integrity of any part of the work are 
appropriately investigated and resolved. The survey has 
been approved by the institutional review boards of the 
Technical University Munich (157/16 S) and written 
informed consent was obtained from all participating 
patients before the start of documentation.
Open Access Statement: This is an Open Access article 
distributed in accordance with the Creative Commons 
Attribution-NonCommercial-NoDerivs 4.0 International 
License (CC BY-NC-ND 4.0), which permits the non-
commercial replication and distribution of the article with 
the strict proviso that no changes or edits are made and the 
original work is properly cited (including links to both the 
formal publication through the relevant DOI and the license). 
See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
1. Mutluer FO, Celiker A. General Concepts in Adult 
Congenital Heart Disease. Balkan Med J 2018;35:18-29.
2. van der Linde D, Konings EE, Slager MA, et al. Birth 
prevalence of congenital heart disease worldwide: a systematic 
review and meta-analysis. J Am Coll Cardiol 2011;58:2241‐7.
3. Wren C, O'Sullivan JJ. Survival with congenital heart 
disease and need for follow up in adult life. Heart 
2001;85:438-43.
4. Neidenbach R, Niwa K, Oto O, et al. Improving medical 
care and prevention in adults with congenital heart disease-
reflections on a global problem-part I: development of 
congenital cardiology, epidemiology, clinical aspects, 
heart failure, cardiac arrhythmia. Cardiovasc Diagn Ther 
2018;8:705-15.
5. Khairy P, Ionescu-Ittu R, Mackie AS, et al. Changing 
mortality in congenital heart disease. J Am Coll Cardiol 
2010;56:1149-57.
6. Erikssen G, Liestøl K, Seem E, et al. Achievements in congenital 
heart defect surgery: a prospective, 40-year study of 7038 
528 Kaemmerer et al. Provision of health care for ACHD associated with aortic involvement
© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2021;11(2):518-528 | http://dx.doi.org/10.21037/cdt-20-359
patients. Circulation 2015;131:337-46; discussion 346.
7. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/
ACC Guideline for the Management of Adults With 
Congenital Heart Disease: Executive Summary: A Report 
of the American College of Cardiology/American Heart 
Association Task Force on Clinical Practice Guidelines. 
Circulation 2019;139:e637‐97.
8. Neidenbach RC, Lummert E, Vigl M, et al. Non-cardiac 
comorbidities in adults with inherited and congenital heart 
disease: report from a single center experience of more 
than 800 consecutive patients. Cardiovasc Diagn Ther 
2018;8:423-31.
9. Singh S, Desai R, Fong HK, et al. Extra-cardiac 
comorbidities or complications in adults with congenital 
heart disease: a nationwide inpatient experience in the 
United States. Cardiovasc Diagn Ther 2018;8:814-9.
10. Lui GK, Rogers IS, Ding VY, et al. Risk Estimates for 
Atherosclerotic Cardiovascular Disease in Adults With 
Congenital Heart Disease. Am J Cardiol 2017;119:112-8.
11. Lui GK, Saidi A, Bhatt AB, et al. Diagnosis and 
Management of Noncardiac Complications in Adults 
With Congenital Heart Disease: A Scientific Statement 
From the American Heart Association. Circulation 
2017;136:e348-92.
12. Perloff JK, Warnes CA. Challenges posed by adults 
with repaired congenital heart disease. Circulation 
2001;103:2637-43.
13. Warnes CA. The adult with congenital heart disease: born 
to be bad? J Am Coll Cardiol 2005;46:1-8.
14. Neidenbach R, Niwa K, Oto O, et al. Improving medical 
care and prevention in adults with congenital heart disease-
reflections on a global problem-part II: infective endocarditis, 
pulmonary hypertension, pulmonary arterial hypertension 
and aortopathy. Cardiovasc Diagn Ther 2018;8:716-24.
15. Niwa K, Kaemmerer H. Aortopathy. Niwa K, Kaemmerer 
H. editors. Tokyo: Springer Japan, 2017.
16. Paruchuri V, Salhab KF, Kuzmik G, et al. Aortic Size 
Distribution in the General Population: Explaining the Size 
Paradox in Aortic Dissection. Cardiology 2015;131:265-72.
17. May Khan A, Kim Y. Aortic dilatation and aortopathies in 
congenital heart disease. Curr Opin Cardiol 2014;29:91-6.
18. Kuijpers JM, Mulder BJ. Aortopathies in adult congenital 
heart disease and genetic aortopathy syndromes: 
management strategies and indications for surgery. Heart 
2017;103:952‐66.
19. von Kodolitsch Y, Rybczynski M, Vogler M, et al. 
The role of the multidisciplinary health care team in 
the management of patients with Marfan syndrome. J 
Multidiscip Healthc 2016;9:587‐14.
20. Niwa K, Perloff JK, Bhuta SM, et al. Structural 
abnormalities of great arterial walls in congenital 
heart disease: light and electron microscopic analyses. 
Circulation 2001;103:393-400.
21. Niwa K. Aortopathy in Congenital Heart Disease in 
Adults: Aortic Dilatation with Decreased Aortic Elasticity 
that Impacts Negatively on Left Ventricular Function. 
Korean Circ J 2013;43:215‐20.
22. Zanjani KS, Niwa K. Aortic dilatation and aortopathy in 
congenital heart diseases. J Cardiol 2013;61:16-21.
23. Niwa K. Aortic dilatation in complex congenital heart 
disease. Cardiovasc Diagn Ther 2018;8:725-38.
24. Niwa K. Aortic root dilatation in tetralogy of Fallot long-
term after repair--histology of the aorta in tetralogy of Fallot: 
evidence of intrinsic aortopathy. Int J Cardiol 2005;103:117-9.
25. Zaidi AN, Kay WA, Daniels CJ, et al. Aortopathy in Adults 
with Congenital Heart Disease. In: da Cruz E, Ivy D, Jaggers J. 
editors. Pediatric and Congenital Cardiology, Cardiac Surgery 
and Intensive Care. London: Springer, 2014:2651-68.
26. Francois K. Aortopathy associated with congenital heart 
disease: A current literature review. Ann Pediatr Cardiol 
2015;8:25-36.
27. Senzaki H, Iwamoto Y, Ishido H, et al. Arterial 
haemodynamics in patients after repair of tetralogy of 
Fallot: influence on left ventricular after load and aortic 
dilatation. Heart 2008;94:70-4.
28. Neidenbach R, Kaemmerer H, Pieper L, et al Striking 
Supply Gap in Adults with Congenital Heart Disease? 
Dtsch Med Wochenschr 2017;142:301-3.
29. Neidenbach R, Pieper L, Freilinger S, et al. Adults with 
congenital heart disease: lack of specific disease related 
medical health care from the patients point of view. Eur 
Heart J 2018;39:111.
30. Neidenbach R, Pieper L, Sanftenberg, et al. Adults with 
congenital heart disease: lack of specific disease related 
medical health care from the general practitioners view. 
Eur Heart J 2018;39:112.
Cite this article as: Kaemmerer AS, Freilinger S, Andonian 
C, Ewert P, Havasi K, Nagdyman N, Pieper L, Nebel K, Seidel 
L, Neidenbach R, Nemes A. Provision of medical health care 
for adults with congenital heart disease associated with aortic 
involvement. Cardiovasc Diagn Ther 2021;11(2):518-528. doi: 
doi: 10.21037/cdt-20-359
